Boston, USA-based biotech Sionna Therapeutics has recently raised $191 million through its initial public offering (IPO), marking a step forward in its efforts to develop treatments for cystic ...

Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

BOSTON, Feb. 27, 2025 /PRNewswire/ -- Thought Industries, the leading platform for customer, partner and professional training, today announced it has been recognized as a Strategic Challenger in ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr ...

A local subsidiary of global conglomerate Danaher has notifed the state that it plans to lay off 85 employees in Massachusetts.

Ginkgo already canceled its plans to move into Biofab1, a new 260,000-square-foot lab data center it's been building near its ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Boston, USA-based biotech Praxis Precision Medicines has provided an update on the interim analysis for Study 1 of the ...